Pro Dex (PDEX) Return on Sales (2010 - 2026)

Pro Dex (PDEX) posted Return on Sales of 0.0% for Q1 2026, up 68.46% sequentially from 0.0% in Q4 2025, and little changed YoY from 0.0% in Q1 2025.

Pro Dex (PDEX) Return on Sales (2010 - 2026) Analysis & Trends

Pro Dex has reported Return on Sales for 14 years, with the latest figure at 0.0% in Q1 2026.

Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Sales rose to 0.0% in Q1 2026 per PDEX's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Sales peaked at 0.0% in Q3 2025 and troughed at 0.0% in Q3 2023.
A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Sales.
The widest YoY moves for Return on Sales: up 0 bps in 2022, down 0 bps in 2022.
Over 5 years, Return on Sales stood at 0.0% in 2022, then slumped by 84 bps to 0.0% in 2023, then surged by 206 bps to 0.0% in 2024, then declined by 4 bps to 0.0% in 2025, then surged by 68 bps to 0.0% in 2026.
According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	0.00%
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	0.00%
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	0.00%
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	0.00%
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	0.00%
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	0.00%
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	0.00%
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	0.00%
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	0.00%
10	Pro Dex	215.72 Mn	204.74 Mn	6.13 Mn	0.00%

Download Data